Cited by 412Liver physiology and pathologyHippo pathway signaling and YAP/TAZLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, Inge, Leite, Sofia Batista, Verhulst, Stefaan, Claerhout, Sofie, Eysackers, Nathalie, Thoen, Lien F.R., Hoorens, Anne, Reynaert, Hendrik, Halder, Georg, van Grunsven, Leo A.·2015·Journal of Hepatology

DOI 10.1016/j.jhep.2015.04.011

Open this paper in CoChat — free account

Abstract

Background & aims Hepatic stellate cell activation is a wound-healing response to liver injury. However, continued activation of stellate cells during chronic liver damage causes excessive matrix deposition and the formation of pathological scar tissue leading to fibrosis and ultimately cirrhosis. The importance of sustained stellate cell activation for this pathological process is well recognized, and several signalling pathways that can promote stellate cell activation have been identified, such as the TGFβ-, PDGF-, and LPS-dependent pathways. However, the mechanisms that trigger and drive the early steps in activation are not well understood. Methods and results We identified the Hippo pathway and its effector YAP as a key pathway that controls stellate cell activation. YAP is a transcriptional co-activator and we found that it drives the earliest changes in gene expression during stellate cell activation. Activation of stellate cells in vivo by CCl4 administration to mice or activation in vitro caused rapid activation of YAP as revealed by its nuclear translocation and by the induction of YAP target genes. YAP was also activated in stellate cells of human fibrotic livers as evidenced by its nuclear localization. Importantly, knockdown of YAP expression or pharmacological inhibition of YAP prevented hepatic stellate cell activation in vitro and pharmacological inhibition of YAP impeded fibrogenesis in mice. Conclusions YAP activation is a critical driver of hepatic stellat…

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2015.04.011

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Role of YAP/TAZ in mechanotransduction
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979
Taking Cell-Matrix Adhesions to the Third Dimension
Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443
YAP1 increases organ size and expands undifferentiated progenitor cells
Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252
The emerging roles of YAP and TAZ in cancer
Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,181
Hippo signaling: growth control and beyond
Halder, G. A., & Johnson, R. L. (2010) · Development · doi:10.1242/dev.045500 · Cited by 1,091
Self-citation
Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937

Show all 46 references

Sorted by citations

Items 201–300 of 412

Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
Schiavoni, G., Messina, B., Scalera, S., Memeo, L., Colarossi, C., Mare, M., Blandino, G., Ciliberto, G., Bon, G., & Maugeri‐Saccà, M. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05027-8 · Cited by 20
Key Anti-Fibrosis Associated Long Noncoding RNAs Identified in Human Hepatic Stellate Cell via Transcriptome Sequencing Analysis
Li, X., Ren, Z., Li, K., Huang, J., Huang, Z., Zhou, T., Cao, H., Zhang, F., & Tan, B. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030675 · Cited by 18
Intricate role of yes‐associated protein1 in human liver cirrhosis: TGF‐β1 still is a giant player
Mohagheghi, S., Geramizadeh, B., Nikeghbalian, S., Khodadadi, I., Karimi, J., Khajehahmadi, Z., Gharekhanloo, F., & Tavilani, H. (2019) · IUBMB Life · doi:10.1002/iub.2052 · Cited by 18
Fibroblast mechanosensing, SKI and Hippo signaling and the cardiac fibroblast phenotype: Looking beyond TGF-β
Landry, N. M., & Dixon, I. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109802 · Cited by 19
Signal Transduction and Molecular Regulation in Fatty Liver Disease
Dong, X. C., Chowdhury, K., Huang, M., & Kim, H.-G. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0076 · Cited by 18
Yes‐associated protein regulates the hepatoprotective effect of vitamin D receptor activation through promoting adaptive bile duct remodeling in cholestatic mice
Xie, J., Fan, Y., Jia, R., Yang, F., Ma, L., & Li, L. (2021) · The Journal of Pathology · doi:10.1002/path.5750 · Cited by 18
Fascin1 empowers YAP mechanotransduction and promotes cholangiocarcinoma development
Pocaterra, A., Scattolin, G., Romani, P., Ament, C. E., Ribback, S., Chen, X., Evert, M., Calvisi, D. F., & Dupont, S. (2021) · Communications Biology · doi:10.1038/s42003-021-02286-9 · Cited by 19
Functionality based method for simultaneous isolation of rodent hepatic sinusoidal cells
Stradiot, L., Verhulst, S., Roosens, T., Øie, C. I., Moya, I. M., Halder, G. A., Mannaerts, I., & van Grunsven, L. A. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.05.047 · Cited by 17
Self-citation
Metabolic Alterations in Spheroid-Cultured Hepatic Stellate Cells
Fujisawa, K., Takami, T., Sasai, N., Matsumoto, T., Yamamoto, N., & Sakaida, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103451 · Cited by 18
Research progress of ankyrin repeat domain 1 protein: an updated review
Xu, X., Wang, X., Yu, L., Chen, R., Wen, H., Wang, Y., & Ma, G. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00647-w · Cited by 19
Implementation of pre-clinical methodologies to study fibrosis and test anti-fibrotic therapy
Oakley, F., Gee, L., Sheerin, N., & Borthwick, L. A. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.10.004 · Cited by 17
Liver knockout YAP gene improved insulin resistance-induced hepatic fibrosis
Dai, Y., Peng, H. F., Sun, Z., Guo, Z., Xu, H., Xue, L., Song, H., Li, Y., Li, S., Gao, M., et al. (2021) · Journal of Endocrinology · doi:10.1530/joe-20-0561 · Cited by 17
Salvianolic acid B exerts an anti-hepatocellular carcinoma effect by regulating the Hippo/YAP pathway and promoting pSmad3L to pSmad3C simultaneously
Xu, W., Shi, Z., Yu, X., Xu, Y., Chen, Y., He, Y., Gong, Y., Huang, C., Tan, C., & Yang, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175423 · Cited by 17
Celastrol Alleviates Corneal Stromal Fibrosis by Inhibiting TGF-β1/Smad2/3-YAP/TAZ Signaling After Descemet Stripping Endothelial Keratoplasty
Liu, R., Li, J., Guo, Z., Chu, D., Li, C., Shi, L., Zhang, J., Zhu, L., & Li, Z. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.9 · Cited by 19
Cell atlas of CCl4-induced progressive liver fibrosis reveals stage-specific responses
Guo, P.-C., 吉林大学动物医学学院人兽共患病研究所人兽共患病研究教育部重点实验室, 人., Zuo, J., Huang, K.-K., Lai, G., Zhang, X., An, J., Li, J., Li, L., Wu, L. L., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.031 · Cited by 19
Portal Hypertension in Nonalcoholic Fatty Liver Disease: Challenges and Paradigms
Mitten, E. K., Portincasa, P., & Baffy, G. (2023) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2023.00029 · Cited by 17
Roles and mechanisms of YAP/TAZ in orthodontic tooth movement
Deng, L., Chen, Y., Guo, J., Han, X., & Guo, Y. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30388 · Cited by 18
Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice
Xu, L., Wettschureck, N., Bai, Y., Yuan, Z., & Wang, S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.02.026 · Cited by 17
Increased matrix stiffness promotes fibrogenesis of hepatic stellate cells through AP-1-induced chromatin priming
Zhao, W., Yuan, W., Dong, T., Qi, W., Feng, Z., Li, C., & Sun, Y. (2025) · Communications Biology · doi:10.1038/s42003-025-08160-2 · Cited by 16
Mechanisms of fibrosis in iatrogenic laryngotracheal stenosis: New discoveries and novel targets
Xu, M., Hu, B., Chen, J., Wang, J., & Li, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115995 · Cited by 18
Hippo-Yap signaling in cardiac and fibrotic remodeling
Re, D. P. D. (2022) · Current Opinion in Physiology · doi:10.1016/j.cophys.2022.100492 · Cited by 17
Does Mechanocrine Signaling by Liver Sinusoidal Endothelial Cells Offer New Opportunities for the Development of Anti-fibrotics?
Soydemir, S., Comella, O., Abdelmottaleb, D. I., & Pritchett, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2019.00312 · Cited by 17
TMEM88 modulates the secretion of inflammatory factors by regulating YAP signaling pathway in alcoholic liver disease
Li, L., Yang, C., Li, S., Liu, Y., Li, H.-D., Hu, S., Zhou, H., Wang, J., Shen, H., Meng, X., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01360-y · Cited by 16
In Situ Regulation and Mechanisms of 3D Matrix Stiffness on the Activation and Reversion of Hepatic Stellate Cells
Chen, G., Deng, Y., Xia, B., & Lv, Y. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202560 · Cited by 15
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Xie, L., Chen, H., Zhang, L., Zhou, Y., Yang, Y.-Y., Liu, C., Wang, Y., Ma, Y., Yan, Y.-J., Ding, J., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0506 · Cited by 15
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Lee, N. Y., Choi, M. G., Lee, E. J., & Koo, J. H. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01501-5 · Cited by 17
TKF, a mexicanolide-type limonoid derivative, suppressed hepatic stellate cells activation and liver fibrosis through inhibition of the YAP/Notch3 pathway
Yang, T., Wu, E., Zhu, X., Leng, Y., Ye, S., Dong, R., Liu, J., Zhong, J., Zheng, Y., Xu, W., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154466 · Cited by 14
Glimpses into the molecular pathogenesis of Peyronie’s disease
ten Dam, E.-J. P. M., van Driel, M. F., de Jong, I. J., Werker, P. M. N., & Bank, R. A. (2020) · The Aging Male · doi:10.1080/13685538.2019.1643311 · Cited by 15
MitoQ alleviates carbon tetrachloride-induced liver fibrosis in mice through regulating JNK/YAP pathway
Shan, S., Liu, Z., Liu, Z., Zhang, C., & Song, F. (2022) · Toxicology Research · doi:10.1093/toxres/tfac062 · Cited by 14
Dual-Targeting Macrophages and Hepatic Stellate Cells by Modified Albumin Nanoparticles for Liver Cirrhosis Treatment
Tan, Y., Wang, Z., Guo, R., Zhou, X., Zhang, W., Wu, M., Guo, C., Gao, H., Sun, X., Zhang, Z., et al. (2024) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17670 · Cited by 16
Dopamine Receptor D1 Is Exempt from Transforming Growth Factor β-Mediated Antifibrotic G Protein-Coupled Receptor Landscape Tampering in Lung Fibroblasts
Gao, A. Y., Espinosa, A. M. D., Nguyen, B. B. N., Link, P. A., Meridew, J. A., Jones, D. L., Gibbard, D. F., Tschumperlin, D. J., & Haak, A. J. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.122.001442 · Cited by 13
Knockdown of Yap attenuates TAA-induced hepatic fibrosis by interaction with hedgehog signals
Zhao, Y., Wang, H., He, T., Ma, B., Chen, G., & Tzeng, C. (2023) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-023-00775-6 · Cited by 13
Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells
Fu, J., Liu, W., Liu, S., Zhao, R., Hayashi, T., Zhao, H., Xiang, Y., Mizuno, K., Hattori, S., Fujisaki, H., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2024.111186 · Cited by 13
Inflammatory and Non-Inflammatory Mechanisms Controlling Cirrhosis Development
Sánchez, P. S., Rigual, M. D. M., & Djouder, N. (2021) · Cancers · doi:10.3390/cancers13205045 · Cited by 13
Hippo signaling in cardiac fibroblasts during development, tissue repair, and fibrosis
Tsai, C.-R., & Martin, J. F. (2022) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2022.02.010 · Cited by 14
Human umbilical cord-derived mesenchymal stromal cells alleviate liver cirrhosis through the Hippo/YAP/Id1 pathway and macrophage-dependent mechanism
Yao, L., Hu, X., Yuan, M., Liu, P., Zhang, Q., Wang, Z., Chen, P., Xiong, Z., Wu, L., Dai, K., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110456 · Cited by 13
IL-6 family cytokines as potential therapeutic strategies to treat metabolic diseases
Zhao, J., Turpin-Nolan, S. M., & Febbraio, M. A. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155549 · Cited by 12
Nucleocytoplasmic Shuttling of the Mechanosensitive Transcription Factors MRTF and YAP/TAZ
Kofler, M., & Kapùs, A. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_15 · Cited by 12
Controlled fabrication of functional liver spheroids with microfluidic flow cytometric printing
Zhang, P., Li, X., Chen, J. Y., & Abate, A. R. (2022) · Biofabrication · doi:10.1088/1758-5090/ac8622 · Cited by 12
Complement complex 1 subunit q‐mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases
Eguchi, A., Iwasa, M., Sugimoto, R., Tempaku, M., Yoshikawa, K., Yoshizawa, N., Povero, D., Sugimoto, K., Hasegawa, H., Takei, Y., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2097 · Cited by 12
Regulatory Functions and Mechanisms of Circular RNAs in Hepatic Stellate Cell Activation and Liver Fibrosis
Nokkeaw, A., Thamjamrassri, P., Tangkijvanich, P., & Ariyachet, C. (2023) · Cells · doi:10.3390/cells12030378 · Cited by 13
The Hippo signaling pathway: from multiple signals to the hallmarks of cancers
Zhu, N., Yang, R., Wang, X., Yuan, L., Li, X., Wei, F., & Zhang, L. (2023) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2023035 · Cited by 13
Dynamic YAP expression in the non-parenchymal liver cell compartment controls heterologous cell communication
Liu, K., Wehling, L., Wan, S., Weiler, S. M. E., Tóth, M., Ibberson, D., Marhenke, S., Ali, A., Lam, M., Guo, T., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05126-1 · Cited by 15
A new, easily generated mouse model of diabetic kidney fibrosis
He, X., Zhang, T., Tolosa, M. F., Goru, S. K., Chen, X., Misra, P. S., Robinson, L. A., & Yuen, D. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-49012-4 · Cited by 12
Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate
Ménard, A., Nader, N. A., Levasseur, A., St‐Jean, G., Roy, M. L. G.-L., Boerboom, D., Benoit‐Biancamano, M., & Boyer, A. (2020) · Endocrinology · doi:10.1210/endocr/bqaa052 · Cited by 12
YAP contributes to liver injury through mediating capillarization of liver sinusoidal endothelial cells via GATA6/eNOS signaling
Wang, J., Shen, Z., Chen, G., Dai, W., Mei, Z., Shen, B., Guo, Y., Wang, J., Zhangdi, H., Zhang, Q., et al. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00798-4 · Cited by 12
ANKRD1 and SPP1 as diagnostic markers and correlated with immune infiltration in biliary atresia
Kong, M., Ma, T., & Xiang, B. (2021) · Medicine · doi:10.1097/md.0000000000028197 · Cited by 11
Prolyl isomerase Pin1 promotes extracellular matrix production in hepatic stellate cells through regulating formation of the Smad3-TAZ complex
Aoyama, S., Kido, Y., Kanamoto, M., Naito, M., Nakanishi, M., Kanna, M., Yamamotoya, T., Asano, T., & Nakatsu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113544 · Cited by 11
Liver transcriptome profiles of dairy cows with different serum metabotypes
Ghaffari, M. H., Sadri, H., Trakooljul, N., Koch, C., & Sauerwein, H. (2023) · Journal of Dairy Science · doi:10.3168/jds.2023-23572 · Cited by 11
The effects of TGF-β-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells
Wilhelmsen, I., Combriat, T. M. D., Dalmao‐Fernández, A., Stokowiec, J., Wang, C., Olsen, P. A., Wik, J. A., Boichuk, Y., Aizenshtadt, A., & Krauss, S. J. K. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03852-8 · Cited by 13
Jiawei Qi Gong Wan improves liver fibrosis and inflammation in PCOS mice via the Akt2-FoxO1 and YAP/TAZ signaling pathways
Li, J., Zheng, R., Shen, Y., Zhuo, Y., Lu, L., Song, J., Li, J., Lai, M., Zhu, H., Hu, M., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156294 · Cited by 12
Repurposing verteporfin and hyaluronic acid gel for ocular surface treatment to prevent corneal scarring
Chen, F., Kang, N.-W., Wungcharoen, T., Jiang, L., Basco, C. A., Garcia-Sanchez, J., Lin, D., Seo, Y. A., Jang, K., Myung, D. J., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.051 · Cited by 13
Tribbles homolog 2 promotes hepatic fibrosis and hepatocarcinogenesis through phosphatase 1A‐Mediated stabilization of yes‐associated protein
Xiang, D., Zhu, X., Zhang, Y., Zou, J., Li, J., Kong, L., & Zhang, H. (2021) · Liver International · doi:10.1111/liv.14782 · Cited by 11
USP10 promotes migration and cisplatin resistance in esophageal squamous cell carcinoma cells
Hou, S., Zhao, T., Deng, B., Li, C., Li, W., Huang, H., & Hang, Q. (2023) · Medical Oncology · doi:10.1007/s12032-023-02272-7 · Cited by 10
O-GlcNAcylation controls pro-fibrotic transcriptional regulatory signaling in myofibroblasts
Very, N., Boulet, C., Gheeraert, C., Berthier, A., Johanns, M., Saleh, M. B., Guille, L., Bray, F., Strub, J., Bobowski, M., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06773-9 · Cited by 12
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells
Park, S., Kim, J., Yang, S., Kang, S. H., Kang, W., & Paik, Y. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09868-w · Cited by 10
Wedelolactone Attenuates Liver Fibrosis and Hepatic Stellate Cell Activation by Suppressing the Hippo Pathway
Zhang, W., Gao, K., Bai, Y., Xu, D., Zhao, M., Tao, X., & Wang, J. (2024) · Rejuvenation Research · doi:10.1089/rej.2024.0053 · Cited by 10
The Hippo Signaling Pathway Manipulates Cellular Senescence
Miyajima, C., Nagasaka, M., Aoki, H., Toriuchi, K., Yamanaka, S., Hashiguchi, S., Morishita, D., Aoyama, M., Hayashi, H., & Inoue, Y. (2024) · Cells · doi:10.3390/cells14010013 · Cited by 10
Focal adhesion kinase inhibitors in fibrotic diseases therapy: Development and therapeutic potential
Gan, C., Wei, W., Xue, T., Xie, Y., Yue, L., Su, X., Yan, Y., Liu, Z., & Ye, T. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117882 · Cited by 12
TrendyGenes, a computational pipeline for the detection of literature trends in academia and drug discovery
Nájera, G. S., Narganes-Carlón, D., & Crowther, D. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94897-9 · Cited by 9
Dysregulation of the Scribble/YAP/β‐catenin axis sustains the fibroinflammatory response in a PKHD1 −/− mouse model of congenital hepatic fibrosis
Fabris, L., Milani, C., Fiorotto, R., Mariotti, V., Kaffe, E., Seller, B., Sonzogni, A., Strazzabosco, M., & Cadamuro, M. (2022) · The FASEB Journal · doi:10.1096/fj.202101924r · Cited by 11
A critical review on anti‐fibrotic phytochemicals targeting activated hepatic stellate cells
Vijayan, N., & Perumal, M. K. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14438 · Cited by 10
The effects of taraxasterol on liver fibrosis revealed by RNA sequencing
He, H., Xu, B., Ge, P., Gao, Y., Wei, M., Li, T., Zhang, R., Li, B., Cao, H., & Zhang, K. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109481 · Cited by 10
Denervation Drives YAP/TAZ Activation in Muscular Fibro/Adipogenic Progenitors
Gallardo, F. S., Córdova-Casanova, A., Bock-Pereda, A., Rebolledo, D. L., Ravasio, A., Casar, J. C., & Brandan, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065585 · Cited by 12
RASSF4 Attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease Progression via Hippo Signaling and Suppresses Hepatocarcinogenesis
Xu, C., Fang, T., Qu, J., Miao, Y., Tian, L., Zhang, M., Zhuang, H., Sun, B., & Chen, L. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.04.005 · Cited by 12
N-Acetyl-l-tryptophan inhibits CCl4-induced hepatic fibrogenesis via regulating TGF-β1/SMAD and Hippo/YAP1 signal
Ma, T., Cheng, H., Li, T., Chen, Y., Cai, T., Bai, J., Wu, Z., Xia, X., Liang, T., Du, Y., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105899 · Cited by 10
Alcohol-Associated Hepatocarcinogenesis
Xue, Y., Tian, T., Ottallah, M., Mannan, M., Barkin, J., Jin-Smith, B., & Pi, L. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.04.016 · Cited by 10
Melatonin and cisplatin co-treatment against cancer: A mechanistic review of their synergistic effects and melatonin’s protective actions
Rafiyan, M., Davoodvandi, A., Reiter, R. J., Mansournia, M. A., Manesh, S. M. R., Arabshahi, V., & Asemi, Z. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155031 · Cited by 9
Gingival proteomics reveals the role of TGF beta and YAP/TAZ signaling in Raine syndrome fibrosis
Costa, C. R. R., Chalgoumi, R., Baker, A., Guillou, C., Yamaguti, P. M., Escorcia, V. H. S., Abbad, L., Amorin, B., de Lima, C. L., Cannaya, V., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59713-0 · Cited by 9
YAP Activation and Implications in Patients and a Mouse Model of Biliary Atresia
Zheng, C., Luo, J., Yang, Y., Dong, R., Yu, F., & Zheng, S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2020.618226 · Cited by 9
Signalling of the neuropeptide calcitonin gene-related peptide (CGRP) through RAMP1 promotes liver fibrosis via TGFβ1/Smad2 and YAP pathways
Wang, Y., Stoess, C., Holzmann, G., Mogler, C., Stupakov, P., Altmayr, F., Schulze, S., Wang, B., Steffani, M., Frieß, H., et al. (2024) · Experimental Cell Research · doi:10.1016/j.yexcr.2024.114193 · Cited by 8
Roles of Yes-associated protein and transcriptional coactivator with PDZ-binding motif in non-neoplastic liver diseases
Chen, D., Zhang, H., Zhang, X., Sun, X., Qin, Q., Hou, Y., Jia, M., & Chen, Y. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113166 · Cited by 8
YAP mediated mechano-homeostasis — conditioning 3D animal body shape
Asaoka, Y., & Furutani‐Seiki, M. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.11.013 · Cited by 8
Glucocorticoids activate Yes-associated protein in human vocal fold fibroblasts
Nakamura, R., Bing, R., Doyle, C. P., Garabedian, M. J., & Branski, R. C. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112681 · Cited by 8
CD133‐Src‐TAZ signaling stimulates ductal fibrosis following DDC diet‐induced liver injury
Oh, H. T., Heo, W., Yoo, G. D., Kim, K. M., Hwang, J., Hwang, E. S., Ko, J., Ko, Y., & Hong, J. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30899 · Cited by 7
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology
Ye, L., Ziesch, A., Schneider, J. S., Ofner, A., Nieß, H., Denk, G., Hohenester, S. D., Mayr, D. C., Mahajan, U. M., Munker, S., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.0602 · Cited by 10
Keeping fibroblasts in suspense: TAZ-mediated signaling activates a context-dependent profibrotic phenotype. Focus on “TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression”
Piersma, B., & Bank, R. A. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00362.2016 · Cited by 8
Formononetin Mitigates Liver Fibrosis via Promoting Hepatic Stellate Cell Senescence and Inhibiting EZH2/YAP Axis
Yuan, Z., Meng, J., Shen, X., Wang, M., Yu, Y., Shi, L., Li, Y., Hassan, H. M., Li, H., He, Z., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05529 · Cited by 8
Turning sublimed sulfur and bFGF into a nanocomposite to accelerate wound healing via co-activate FGFR and Hippo signaling pathway
Cao, J., Su, Z., Zhang, Y., Chen, Z., Li, J., Cai, Y., Chang, Y., Lei, M., He, Q., Li, W., et al. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101104 · Cited by 7
Taz/Tead1 Promotes Alternative Macrophage Activation and Kidney Fibrosis via Transcriptional Upregulation of Smad3
Ren, Y., Zhou, L., Li, X., Zhu, X., Zhang, Z., Sun, X., Xue, X., & Dai, C. (2024) · Journal of Immunology Research · doi:10.1155/2024/9512251 · Cited by 7
WAVE2 Enhanced Hepatic Stellate Cells Activity in Colorectal Liver Metastases
Tan, F., He, D., Hu, K., Wang, D., Zhang, S., Li, J., Wang, Z., & Tao, Y. (2020) · Cancer Management and Research · doi:10.2147/cmar.s259125 · Cited by 7
Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
Cavanzo, N. P., Riesmeijer, S. A., Holt-Kedde, I. L., Werker, P., Piersma, B., Olinga, P., & Bank, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-18116-9 · Cited by 5
COL1A1 expression induced by overexpression of both a 15‑amino acid peptide from the fibrinogen domain of tenascin‑X and integrin α11 in LX‑2 cells
Matsumoto, K., Kawakami, K., Yamada, K., & Takeshita, H. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12846 · Cited by 8
Yes-associated protein: A novel molecular target for the diagnosis, treatment and prognosis of hepatocellular carcinoma
Shan, L., Jiang, H., Ma, L., & Yu, Y. (2017) · Oncology Letters · doi:10.3892/ol.2017.6622 · Cited by 8
Inhibiting xCT/SLC7A11 induces ferroptosis of myofibroblastic hepatic stellate cells and protects against liver fibrosisPreprint
Du, K., Oh, S., Sun, T., Yang, W., Chi, J., & Diehl, A. M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2019.12.23.886259 · Cited by 7
Chikusetsusaponin IVa targeted YAP as an inhibitor to attenuate liver fibrosis and hepatic stellate cell activation
Gao, K., Zhang, W., Xu, D., Zhao, M., Tao, X., Lu, Y., & Wang, J. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01090-5 · Cited by 7
Daidzein alleviates CCl 4 - and BDL-induced liver fibrosis via suppressing the integrin alphaVbeta1/YAP signaling
Bai, J., Yang, Z., Wang, P., Qian, B., Jiang, Z., Xu, T., Pu, H., Ye, M., Du, Y., & Fu, W. (2025) · Food & Function · doi:10.1039/d5fo01024a · Cited by 6
Why Stress Matters: An Introduction
Tschumperlin, D. J. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_12 · Cited by 6
Cell-Type Resolved Insights into the Cis-Regulatory Genome of NAFLD
Dam, T. V., Toft, N. I., & Grøntved, L. (2022) · Cells · doi:10.3390/cells11050870 · Cited by 6
Macrophages-derived exosomal non-coding RNA circ_0055194 regulating miR-665/YAP1/Twist axis is involved in pulmonary fibrosis induced by Nd2O3
He, Y., Zhao, Y., Wu, K. C., Qi, D., Ma, Y., Li, W., Chang, X., Wang, S., & Gao, Y. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126542 · Cited by 5
Lawsone can suppress liver fibrosis by inhibition of YAP signaling and induction of CYGB expression in hepatic stellate cells
Daikoku, A., Matsubara, T., Sato-Matsubara, M., Ando, M., Kadono, C., Takada, S., Odagiri, N., Yuasa, H., Urushima, H., Yoshizato, K., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118520 · Cited by 5
Activation of the Integrin αV-YAP-CTGF Axis in Liver Sinusoidal Endothelial Cells Promotes Liver Fibrogenesis, Leading to Portal Hypertension and Liver Carcinogenesis in Congestive Hepatopathy
Kato, S., Hikita, H., Tsukamoto, O., Sato, K., Kamizono, K., Sasaki, Y., Fukumoto, K., Myojin, Y., Murai, K., Tahata, Y., et al. (2026) · Gastroenterology · doi:10.1053/j.gastro.2025.11.014 · Cited by 5
A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy
Liu, M., Ma, Y., Cheang, W. S., Su, Z., & Xu, S. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.04.011 · Cited by 8
Involvement of lysophosphatidic acid-LPA1-YAP signaling in healthy and pathological FAPs migration
Bock-Pereda, A., Cruz-Soca, M., Gallardo, F. S., Córdova-Casanova, A., Gutiérrez‐Rojas, C., Faundez-Contreras, J., Chun, J. J. M., Casar, J. C., & Brandan, E. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.005 · Cited by 8
Hepatic connective tissue growth factor expression and regulation differ between non-steatotic and non-alcoholic steatotic livers from brain-dead donor
Yang, D., Shi, J., Xia, Z., Guo, W.-Z., Ahmed, M. S., & Zhang, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-83516-2 · Cited by 5
Arg-Gly-Asp-binding integrins activate hepatic stellate cells via the hippo signaling pathway
Kitsugi, K., Noritake, H., Matsumoto, M., Hanaoka, T., Umemura, M., Yamashita, M., Takatori, S., Ito, J., Ohta, K., Chida, T., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110437 · Cited by 5
Mechanotransduction in fibrosis: Mechanisms and treatment targets
Yeh, C., Chou, C. E. N., & Yang, K. (2021) · Current topics in membranes · doi:10.1016/bs.ctm.2021.07.004 · Cited by 4
Review: Challenges of In Vitro CAF Modelling in Liver Cancers
Herrero, A., Knetemann, E., & Mannaerts, I. (2021) · Cancers · doi:10.3390/cancers13235914 · Cited by 5
Self-citation
Orphan receptor GPR176 in hepatic stellate cells exerts a profibrotic role in chronic liver disease
Smet, V. D., Gürbüz, E., Eysackers, N., Dewyse, L., Smout, A., Dastjerd, M. K., Lefesvre, P., Messaoudi, N., Reynaert, H., Verhulst, S., et al. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101036 · Cited by 4
Self-citation
Reply to: “Myofibroblast YAP/TAZ is dispensable for liver fibrosis in mice”
Liu, Y., Xu, N., & Ji, H. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.014 · Cited by 5

Authors: Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A.
Affiliations: Vrije Universiteit Brussel (BE)
KU Leuven (BE)
Universitair Ziekenhuis Brussel (BE)
Corresponding author: van Grunsven, Leo A.
ORCID: Mannaerts, Inge
Leite, Sofia Batista
Verhulst, Stefaan
Claerhout, Sofie
Hoorens, Anne
Reynaert, Hendrik
Halder, Georg
van Grunsven, Leo A.
Venue: Journal of Hepatology
Publisher: Elsevier BV
Published: 2015-09
Volume: 63
Issue: 3
Pages: 679-688
ISSN: 0168-8278 (ISSN-L)
DOI: 10.1016/j.jhep.2015.04.011
OpenAlex: W2154530183
Cited by: 410
References: 46
Citations by year: 2026: 37 · 2025: 44 · 2024: 43 · 2023: 29 · 2022: 60 · 2021: 49 · 2020: 35 · 2019: 38 · 2018: 29 · 2017: 23 · 2016: 19 · 2015: 4
FWCI: 14.82
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Hepatology (publishedVersion)
PubMed (publishedVersion)
Ghent University Academic Bibliography (Ghent University) (submittedVersion)
VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: YAP, Hippo signaling pathway, hepatic stellate cell activation, liver fibrosis, YAP inhibition, carbon tetrachloride-induced liver injury, nuclear translocation, transcriptional coactivator, liver cirrhosis, fibrogenesis
MeSH terms: Hippo Signaling Pathway, YAP-Signaling Proteins, Animals, Humans, Liver Cirrhosis, Mice, Inbred BALB C, Phosphoproteins, Transcription Factors, Signal Transduction, Protein Serine-Threonine Kinases, Cell Cycle Proteins, Adaptor Proteins, Signal Transducing, Mice, Hepatic Stellate Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks